Loading...
Please wait, while we are loading the content...
Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Ånensen, Nina Haaland, Ingvild D'Santos, Clive S. Belle, Werner Van Gjertsen, Bjørn Tore |
| Copyright Year | 2006 |
| Abstract | The anti-oncogene TP53 is frequently mutated in human cancer, but in hematological malignancies this is a rare feature. In acute myeloid leukemia (AML) more than 90% of the patients comprise wild type TP53 in their cancer cells, but if TP53 is mutated or deleted the disease is often found to be chemoresistant. In this review we define proteomics of the oncogene product p53 as the study of proteins in the p53 regulating signaling networks, as well as the protein study of members of the p53 family itself. Various messenger RNA splice forms as well as a multitude of post-translational modifications give a high number of protein isoforms in the p53 family. Some of the proteomic techniques allow detection of various isoforms, such as two-dimensional gel electrophoresis in combination with tandem mass spectrometry (MS/MS) and this methodology may therefore increasingly be used as a diagnostic tool in human disease. We introduce the p53 protein as an illustration of the complexity of post-translational modifications that may affect one highly connected protein and discuss the possible impact in AML diagnostics if the p53 profile is reflecting cell stress and status of signal transduction systems of the malignancy. |
| Starting Page | 199 |
| Ending Page | 207 |
| Page Count | 9 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://werner.yellowcouch.org/Papers/p53proteo/Gjertsen-MS.pdf |
| PubMed reference number | 16789904v1 |
| Volume Number | 7 |
| Issue Number | 3 |
| Journal | Current pharmaceutical biotechnology |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Electrophoresis, Gel, Two-Dimensional Gel Electrophoresis (lab technique) Genetic Translation Process Hematologic Neoplasms Leukemia, Myelocytic, Acute Myeloid Leukemia Oncogene Proteins Oncogenes Patients Post-Translational Protein Processing Protein Isoforms Proteomics RNA Signal Transduction Tandem Mass Spectrometry Tumor Suppressor Genes Wild Type |
| Content Type | Text |
| Resource Type | Article |